This study aimed to predict the efficacy of nivolumab based on a comprehensive analysis of RNA expression in advanced NSCLC, finding that different gene expression patterns are predictors of the effectiveness of anti PD-1 antibody therapy in adenocarcinoma and squamous cell carcinoma. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.